Table 1: Demographic and Clinical Characteristics - COPD - LAMA monotherapy
	Total	LABA/LAMA Combination	ICS Dual Combination	Other

1	  292,097 (100.0)	   79,581 (100.0)	  105,249 (100.0)	  107,267 (100.0)

Grouped age
1	    1,235 (0.4)	      151 (0.2)	      184 (0.2)	      900 (0.8)
2	   10,046 (3.4)	    1,931 (2.4)	    2,291 (2.2)	    5,824 (5.4)
3	   40,956 (14.0)	   10,502 (13.2)	   12,245 (11.6)	   18,209 (17.0)
4	   80,874 (27.7)	   22,895 (28.8)	   29,530 (28.1)	   28,449 (26.5)
5	  104,405 (35.7)	   29,628 (37.2)	   40,380 (38.4)	   34,397 (32.1)
6	   54,581 (18.7)	   14,474 (18.2)	   20,619 (19.6)	   19,488 (18.2)

Male
0	  133,885 (45.8)	   36,479 (45.8)	   48,731 (46.3)	   48,675 (45.4)
1	  158,212 (54.2)	   43,102 (54.2)	   56,518 (53.7)	   58,592 (54.6)

Grouped BMI
1	   11,366 (3.9)	    2,996 (3.8)	    4,740 (4.5)	    3,630 (3.4)
2	   89,275 (30.6)	   24,022 (30.2)	   31,865 (30.3)	   33,388 (31.1)
3	   95,543 (32.7)	   26,269 (33.0)	   33,514 (31.8)	   35,760 (33.3)
4	   55,582 (19.0)	   15,596 (19.6)	   20,281 (19.3)	   19,705 (18.4)
5	   22,082 (7.6)	    6,268 (7.9)	    8,386 (8.0)	    7,428 (6.9)
6	   10,018 (3.4)	    2,729 (3.4)	    3,948 (3.8)	    3,341 (3.1)
.	    8,231 (2.8)	    1,701 (2.1)	    2,515 (2.4)	    4,015 (3.7)

Smoking status
.	        0 (0.0)	        0 (0.0)	        0 (0.0)	        0 (0.0)
2	  184,571 (63.2)	   47,774 (60.0)	   69,740 (66.3)	   67,057 (62.5)
3	  107,526 (36.8)	   31,807 (40.0)	   35,509 (33.7)	   40,210 (37.5)
.	        0 (0.0)	        0 (0.0)	        0 (0.0)	        0 (0.0)

Ethnicity
1	  219,008 (75.0)	   59,469 (74.7)	   79,735 (75.8)	   79,804 (74.4)
2	      676 (0.2)	      172 (0.2)	      182 (0.2)	      322 (0.3)
3	    3,369 (1.2)	      630 (0.8)	      836 (0.8)	    1,903 (1.8)
4	    1,210 (0.4)	      233 (0.3)	      301 (0.3)	      676 (0.6)
5	    1,061 (0.4)	      236 (0.3)	      289 (0.3)	      536 (0.5)
.	   66,773 (22.9)	   18,841 (23.7)	   23,906 (22.7)	   24,026 (22.4)

Index of Multiple Deprivation (IMD)
1	   58,944 (20.2)	   15,462 (19.4)	   19,896 (18.9)	   23,586 (22.0)
2	   58,848 (20.1)	   15,887 (20.0)	   20,629 (19.6)	   22,332 (20.8)
3	   59,247 (20.3)	   16,138 (20.3)	   21,244 (20.2)	   21,865 (20.4)
4	   57,682 (19.7)	   15,635 (19.6)	   21,641 (20.6)	   20,406 (19.0)
5	   57,376 (19.6)	   16,459 (20.7)	   21,839 (20.7)	   19,078 (17.8)
.	        0 (0.0)	        0 (0.0)	        0 (0.0)	        0 (0.0)

Diabetes Severity
1	  221,389 (75.8)	   60,251 (75.7)	   79,549 (75.6)	   81,589 (76.1)
2	   51,349 (17.6)	   14,089 (17.7)	   19,030 (18.1)	   18,230 (17.0)
3	   18,577 (6.4)	    5,049 (6.3)	    6,366 (6.0)	    7,162 (6.7)
4	      782 (0.3)	      192 (0.2)	      304 (0.3)	      286 (0.3)
.	        0 (0.0)	        0 (0.0)	        0 (0.0)	        0 (0.0)



Single SABA
0	  125,214 (42.9)	   25,709 (32.3)	   21,566 (20.5)	   77,939 (72.7)
1	  166,883 (57.1)	   53,872 (67.7)	   83,683 (79.5)	   29,328 (27.3)

High Dose ICS
0	  266,397 (91.2)	   79,581 (100.0)	   79,782 (75.8)	  107,034 (99.8)
1	   25,700 (8.8)	        0 (0.0)	   25,467 (24.2)	      233 (0.2)

Low/Medium Dose ICS
0	  204,825 (70.1)	   79,581 (100.0)	   22,743 (21.6)	  102,501 (95.6)
1	   87,272 (29.9)	        0 (0.0)	   82,506 (78.4)	    4,766 (4.4)

Single ICS
0	  284,779 (97.5)	   79,581 (100.0)	  102,924 (97.8)	  102,274 (95.3)
1	    7,318 (2.5)	        0 (0.0)	    2,325 (2.2)	    4,993 (4.7)

Single SAMA
0	  288,777 (98.9)	   79,299 (99.6)	  103,761 (98.6)	  105,717 (98.6)
1	    3,320 (1.1)	      282 (0.4)	    1,488 (1.4)	    1,550 (1.4)

Single LABA
0	  284,018 (97.2)	   77,148 (96.9)	  104,394 (99.2)	  102,476 (95.5)
1	    8,079 (2.8)	    2,433 (3.1)	      855 (0.8)	    4,791 (4.5)

Single LAMA
0	  204,395 (70.0)	   38,718 (48.7)	   59,766 (56.8)	  105,911 (98.7)
1	   87,702 (30.0)	   40,863 (51.3)	   45,483 (43.2)	    1,356 (1.3)

LABA ICS
0	  216,545 (74.1)	   79,581 (100.0)	   29,697 (28.2)	  107,267 (100.0)
1	   75,552 (25.9)	        0 (0.0)	   75,552 (71.8)	        0 (0.0)

LABA LAMA
0	  245,913 (84.2)	   38,204 (48.0)	  100,442 (95.4)	  107,267 (100.0)
1	   46,184 (15.8)	   41,377 (52.0)	    4,807 (4.6)	        0 (0.0)

LABA LAMA ICS
0	  259,057 (88.7)	   79,581 (100.0)	   72,209 (68.6)	  107,267 (100.0)
1	   33,040 (11.3)	        0 (0.0)	   33,040 (31.4)	        0 (0.0)

Single LTRA
0	  292,097 (100.0)	   79,581 (100.0)	  105,249 (100.0)	  107,267 (100.0)
.	        0 (0.0)	        0 (0.0)	        0 (0.0)	        0 (0.0)

Smoking status (missing set to non)
.	        0 (0.0)	        0 (0.0)	        0 (0.0)	        0 (0.0)
.	        0 (0.0)	        0 (0.0)	        0 (0.0)	        0 (0.0)

Chronic kidney disease
0	  242,158 (82.9)	   65,468 (82.3)	   86,886 (82.6)	   89,804 (83.7)
1	   49,939 (17.1)	   14,113 (17.7)	   18,363 (17.4)	   17,463 (16.3)

Diagnosed hypertension
0	  147,010 (50.3)	   39,379 (49.5)	   50,954 (48.4)	   56,677 (52.8)
1	  145,087 (49.7)	   40,202 (50.5)	   54,295 (51.6)	   50,590 (47.2)

Heart Failure
0	  267,454 (91.6)	   72,832 (91.5)	   95,283 (90.5)	   99,339 (92.6)
1	   24,643 (8.4)	    6,749 (8.5)	    9,966 (9.5)	    7,928 (7.4)

Other Heart Diseases
0	  226,533 (77.6)	   61,241 (77.0)	   81,128 (77.1)	   84,164 (78.5)
1	   65,564 (22.4)	   18,340 (23.0)	   24,121 (22.9)	   23,103 (21.5)

Cancer
0	  252,004 (86.3)	   68,423 (86.0)	   90,171 (85.7)	   93,410 (87.1)
1	   40,093 (13.7)	   11,158 (14.0)	   15,078 (14.3)	   13,857 (12.9)

Recent Statin
0	  150,591 (51.6)	   37,735 (47.4)	   50,912 (48.4)	   61,944 (57.7)
1	  141,506 (48.4)	   41,846 (52.6)	   54,337 (51.6)	   45,323 (42.3)

Flu vaccine
0	   73,937 (25.3)	   16,356 (20.6)	   19,917 (18.9)	   37,664 (35.1)
1	  218,160 (74.7)	   63,225 (79.4)	   85,332 (81.1)	   69,603 (64.9)

Pneumococcal Vaccine
0	  231,561 (79.3)	   59,861 (75.2)	   83,943 (79.8)	   87,757 (81.8)
1	   60,536 (20.7)	   19,720 (24.8)	   21,306 (20.2)	   19,510 (18.2)

Exacerbation in last year
0	  236,381 (80.9)	   65,033 (81.7)	   77,897 (74.0)	   93,451 (87.1)
1	   55,716 (19.1)	   14,548 (18.3)	   27,352 (26.0)	   13,816 (12.9)

Immunosuppressed (combination algorithm)
0	  291,348 (99.7)	   79,388 (99.8)	  105,013 (99.8)	  106,947 (99.7)
1	      749 (0.3)	      193 (0.2)	      236 (0.2)	      320 (0.3)

GP consultation count
Median (IQR)	9 (5-16)	10 (6-16)	10 (6-17)	8 (4-14)
Mean (SD)	12.21 (11.72)	12.46 (11.46)	13.46 (12.34)	10.81 (11.12)
Min, Max	0, 510	0, 510	0, 306	0, 268
Exacerbation Count
Median (IQR)	0 (0-0)	0 (0-0)	0 (0-1)	0 (0-0)
Mean (SD)	.26 (.62)	.24 (.57)	.38 (.77)	.16 (.46)
Min, Max	0, 12	0, 9	0, 12	0, 7
Age (years)
Median (IQR)	71 (63-77)	71 (63-77)	72 (64-78)	70 (60-77)
Mean (SD)	69.76 (10.77)	70.13 (10.14)	70.76 (10.06)	68.51 (11.72)
Min, Max	35, 103	35, 102	35, 102	35, 103
